Cel Sci Corp SEC filings CVM
Cel Sci Corp has 1,007 filings in SEC EDGAR's recent list, going back to Jun 12, 2012. Its latest annual report, Form ARS, was filed on Jul 2, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 17, 2026 (shareholder vote results). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Feb 17, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Feb 14, 2025 | Dec 31, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Feb 14, 2024 | Dec 31, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 12, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Feb 14, 2023 | Dec 31, 2022 |
| 10-Q | Quarterly report | Aug 12, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 13, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Feb 11, 2022 | Dec 31, 2021 |
| 10-Q | Quarterly report | Aug 13, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 17, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | Feb 12, 2021 | Dec 31, 2020 |
| 10-Q/A | Amended quarterly report | Dec 31, 2020 | Jun 30, 2020 |
| 10-Q/A | Amended quarterly report | Dec 30, 2020 | Mar 31, 2020 |
| 10-Q/A | Amended quarterly report | Dec 30, 2020 | Dec 31, 2019 |
| 10-Q/A | Amended quarterly report | Aug 11, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | Aug 10, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | May 8, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Feb 10, 2020 | Dec 31, 2019 |
| 10-Q | Quarterly report | Aug 14, 2019 | Jun 30, 2019 |
| 10-Q/A | Amended quarterly report | May 14, 2019 | Mar 31, 2019 |
| 10-Q | Quarterly report | May 14, 2019 | Mar 31, 2019 |
| 10-Q | Quarterly report | Feb 14, 2019 | Dec 31, 2018 |
| 10-Q | Quarterly report | Aug 14, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | May 15, 2018 | Mar 31, 2018 |
| 10-Q | Quarterly report | Feb 12, 2018 | Dec 31, 2017 |
| 10-Q/A | Amended quarterly report | Dec 11, 2017 | Jun 30, 2017 |
| 10-Q/A | Amended quarterly report | Dec 11, 2017 | Mar 31, 2017 |
| 10-Q/A | Amended quarterly report | Dec 11, 2017 | Dec 31, 2016 |
| 10-Q/A | Amended quarterly report | Aug 15, 2017 | Jun 30, 2017 |
| 10-Q | Quarterly report | Aug 9, 2017 | Jun 30, 2017 |
| 10-Q | Quarterly report | May 10, 2017 | Mar 31, 2017 |
| 10-Q | Quarterly report | Feb 9, 2017 | Dec 31, 2016 |
| 10-Q | Quarterly report | Aug 9, 2016 | Jun 30, 2016 |
| 10-Q | Quarterly report | May 10, 2016 | Mar 31, 2016 |
| 10-Q | Quarterly report | Feb 9, 2016 | Dec 31, 2015 |
| 10-Q | Quarterly report | Aug 7, 2015 | Jun 30, 2015 |
| 10-Q | Quarterly report | May 8, 2015 | Mar 31, 2015 |
| 10-Q | Quarterly report | Feb 6, 2015 | Dec 31, 2014 |
| 10-Q | Quarterly report | Aug 8, 2014 | Jun 30, 2014 |
| 10-Q | Quarterly report | May 12, 2014 | Mar 31, 2014 |
| 10-Q | Quarterly report | Feb 10, 2014 | Dec 31, 2013 |
| 10-Q | Quarterly report | Aug 9, 2013 | Jun 30, 2013 |
| 10-Q | Quarterly report | May 10, 2013 | Mar 31, 2013 |
| 10-Q | Quarterly report | Feb 8, 2013 | Dec 31, 2012 |
| 10-Q | Quarterly report | Aug 9, 2012 | Jun 30, 2012 |
Showing 52 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CVM (NYSE)
- Fiscal year ends
- September 30
- Incorporated in
- CO
- Headquarters
- Vienna, VA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 725363
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.